학술논문
First-line treatment with alemtuzumab for active multiple sclerosis: A nationwide post-marketing survey in Austria
Document Type
Abstract
Author
Source
In Journal of the Neurological Sciences 15 October 2017 381 Supplement:796-796
Subject
Language
ISSN
0022-510X